Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Free Cash Flow (2016 - 2025)

Biomerica's Free Cash Flow history spans 16 years, with the latest figure at -$991000.0 for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 25.28% year-over-year to -$991000.0; the TTM value through Nov 2025 reached -$3.0 million, up 40.75%, while the annual FY2025 figure was -$3.8 million, 29.03% up from the prior year.
  • Free Cash Flow for Q4 2025 was -$991000.0 at Biomerica, down from -$268000.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $2.3 million in Q1 2022 and bottomed at -$4.3 million in Q2 2022.
  • The 5-year median for Free Cash Flow is -$1.0 million (2021), against an average of -$951591.0.
  • The largest YoY upside for Free Cash Flow was 266.35% in 2022 against a maximum downside of 2373.15% in 2022.
  • A 5-year view of Free Cash Flow shows it stood at $1.3 million in 2021, then crashed by 193.02% to -$1.2 million in 2022, then skyrocketed by 31.45% to -$848000.0 in 2023, then rose by 6.72% to -$791000.0 in 2024, then dropped by 25.28% to -$991000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Free Cash Flow are -$991000.0 (Q4 2025), -$268000.0 (Q3 2025), and -$661000.0 (Q2 2025).